Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
delanzomib
(CEP-18770) /
Teva
Welcome,
Profile
Billing
Logout
16 Diseases
0 Trials
0 Trials
34 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Disease Category View
Disease View
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Immunoproliferative Disorders
Lymphoproliferative Disorders
Blood Coagulation Disorders
Blood Protein Disorders
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Multiple Myeloma
Neoplasms by Histologic Type
Neoplasms, Plasma Cell
Paraproteinemias
Vascular Diseases
Lymphatic Diseases
Lymphoma
Lymphoma, Non-Hodgkin
Lymphosarcoma
